When a congressional panel investigating the procurement of fetal tissue from abortion clinics was formed last fall, its Republican leader and members made no secret of their mission to expose businesses that “sell baby body parts.” (They even said as
When a congressional panel investigating the procurement of fetal tissue from abortion clinics was formed last fall, its Republican leader and members made no secret of their mission to expose businesses that “sell baby body parts.” (They even said as much on their website.) Their inquiry was inspired by hidden-camera videos (later discredited) that supposedly showed Planned Parenthood officials negotiating over payments for harvested fetal tissue. It’s illegal in the U.S. to profit from the sale of fetal tissue so if the committee actually found organizations doing that, it would be legitimate to bust them.
But so far that hasn’t happened. The House Energy and Commerce Committee’s Select Investigative Panel on Infant Lives has yet to find any proof that anyone is selling or buying fetal tissue. After months of investigation and subpoenas for staggering amounts of records — including, most troublingly, the names of people involved in performing abortions and procuring fetal tissue — the Republican members of the panel released an 88-page interim report this month that is long on innuendo but remarkably short on revelation.
One of the panel’s main findings is actually just speculation: that the University of New Mexico Health Sciences Center might have violated federal law when it awarded faculty positions (without pay but with some benefits) to staff doctors at a local abortion clinic when the clinic was providing fetal tissue for research at the school, raising the specter of a quid pro quo.
The school has categorically denied the allegations and argued that the panel is misreading state law. Nonetheless, the panel referred the matter to the New Mexico state attorney general, whose office is looking into it.
The panel also has asked the U.S. Department of Health and Human Services to investigate whether technicians from a fetal tissue company, StemExpress, violated patient confidentiality laws by looking at patients’ medical records at clinics where they collected tissue. StemExpress told the panel that its technicians did not review medical files — and that the panel would have known this had it interviewed any of the witnesses “repeatedly offered by StemExpress.”
Having found no smoking guns, the panel has passed its allegations to other authorities to settle while it continues to search for criminality. Beyond that, the report does little more than serve the panel’s antiabortion narrative in which clinics are desperate to get more business, fetal tissue companies are intent on getting more product, and the technicians who collect these specimens send out emails blithely discussing fetal organs and limbs.
The real danger here is that the panel’s work will chill the activities of fetal tissue suppliers and the researchers who use it to study retinal degeneration, fetal development, the Zika virus and illnesses such as Alzheimer’s disease. One San Diego stem cell researcher told the panel members in March that a project on multiple sclerosis in which he was involved had already been delayed because fetal material had become scarce. Meanwhile, six states have enacted bans this year on the donation of fetal tissue from abortions, and most of those also bar researchers from using such tissue.
The panel’s ranking Democratic member, Rep. Jan Schakowsky of Illinois, who has called the investigation a witch hunt, joined 181 other Democrats in asking the speaker of the House to disband the panel. That would be the best course. In any case, the panel’s final report is due by Dec. 31, which should spell the end to its existence.
— Los Angeles Times
